InspireMD (NSPR) Total Non-Current Liabilities (2010 - 2025)
InspireMD's (NSPR) quarterly Total Non-Current Liabilities came in at $3.5 million in Q4 2025, up 14.72% year-on-year from $3.0 million in Q4 2024, and down 1.44% quarter-over-quarter from $3.5 million in Q3 2025.
InspireMD (NSPR) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends
InspireMD's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $3.5 million for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 14.72% year-over-year to $3.5 million in Q4 2025; TTM through Dec 2025 was $3.5 million, a 14.72% increase from a year earlier, with the FY2025 full-year figure at $3.5 million, up 14.72% from the prior year.
- Total Non-Current Liabilities fell to $3.5 million in Q4 2025 per NSPR's latest filing, from $3.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $4.0 million in Q2 2025 and bottomed at $1.8 million in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $2.1 million (2023), against an average of $2.4 million.
- Across the five-year window, Total Non-Current Liabilities slipped 13.67% in 2023 and jumped 108.75% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $1.8 million in 2021, then grew by 19.48% to $2.2 million in 2022, then retreated by 3.11% to $2.1 million in 2023, then jumped by 43.4% to $3.0 million in 2024, then gained by 14.72% to $3.5 million in 2025.
- Per Business Quant, the three latest NSPR Total Non-Current Liabilities figures stand at $3.5 million (Q4 2025), $3.5 million (Q3 2025), and $4.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | 3.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.49 Mn |
| Sep 30, 2025 | 3.54 Mn |
| Jun 30, 2025 | 4.03 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 1.93 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 2.19 Mn |
| Sep 30, 2022 | 2.23 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 1.82 Mn |
| Jun 30, 2021 | 1.87 Mn |
| Mar 31, 2021 | 1.82 Mn |